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1. Introduction 
Acute kidney injury (AKI) is a frequent event associated with decreased allograft survival in 
patients with transplanted kidneys and high mortality in patients with native kidneys (1,2). 
AKI is a common complication in hospitalized patients, and its incidence has risen 
substantially over the past 15 years (1-3). As a conservative estimate, roughly 17 million 
admissions annually in the United States are complicated by AKI, resulting in over $10 
billion in costs to the health care system (4). Kidney transplants from living unrelated 
donors (not well HLA matched) with minimal ischemic injury have improved allograft 
survival, compared with grafts from well matched cadaveric donors with significant 
ischemia (5, 6). This implies that renal ischemia reperfusion injury (IRI) can have important 
consequences on long-term graft survival and native kidneys.  
IRI is a highly complex cascade of events that includes interactions between vascular 
endothelium, interstitial compartments, circulating cells, and numerous mediator molecules 
(7). Renal ischemic injury has been found to permanently damage peritubular capillaries 
causing hypoxia, which may be involved in the progression of chronic renal disease after 
AKI (7, 8). Tubulointerstitial influx of inflammatory cells is found in many forms of chronic 
renal diseases, including ‘nonimmune’ diseases such as diabetes and hypertension (9). T-
lymphocyte infiltration has also been observed early after moderate ischemia injury (10,11) 
however, the dynamics of infiltrating lymphocyte populations long term after moderate or 
severe ischemic injury is not very clear.  
It has been demonstrated that T and B lymphocytes are important mediators in the 
pathogenesis of renal IRI (10, 12) however, the mechanisms by which these cells induce 
kidney injury is largely unknown. The trafficking of pathogenic lymphocytes into kidneys 
after moderate and severe ischemic injury has been postulated to contribute to kidney 
damage (11, 13, 14) however the physiologic state and the dynamics of trafficking of these 
populations long term after ischemia have not been rigorously studied. Furthermore, the 
activation and expression of the effector-memory phenotype by infiltrated lymphocytes 
suggests the possibility that these lymphocytes are responding to an injury-associated 
antigen (15, 16). In addition, these lymphocytes are responsible to produce inflammatory 
mediators not only causing local kidney structure damage, but also the severe effects  
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on the other long distance organs, including lung, hearth, intestine, brain, liver, bone 
medulla. 
Here we describe the trafficking of T lymphocytes into the mice (male C57BL/6J) kidneys 
both, in normal mice, earlier (3 to 24 h), and long term (1 to 11 weeks) after the renal injury 
was performed as previously described (17, 18, 19). The different T cell phenotypes and 
cytokine/chemokines raised at different times are compared with the baseline level cells 
maintained in normal kidneys (17). In the long term studies, to make our observations 
clinically relevant for both allograft and native kidneys, we have studied these phenomena 
in both a moderate bilateral ischemia (a kin to ischemia in native kidneys) and a severe 
unilateral ischemia (a kin to IRI in an allograft). The different kidney infiltrating T cell 
phenotypes and its effector molecules raised at different times after ischemia injury are 
presented and discussed. 
2. Overview of experimental acute kidney injury 
The mechanisms involved in renal ischemia-reperfusion injury (IRI) are complex (20, 21), 
invoking both innate and adaptive immunity (22, 23). Following IR, the cascade of events 
leading to endothelial cell dysfunction, tubular epithelial cell injury and activation of tissue-
resident and infiltrating leukocytes consists of the coordinated action of 
cytokines/chemokines, reactive oxygen intermediates and adhesion molecules (21, 23). The 
early phase of innate immune response to IR begins within minutes of reperfusion, whereas 
the late phase adaptive response requires days to manifest. For our experiments, a well-
established model of renal IRI in mice was used (17, 18, and 19). 
3. Early trafficking of T lymphocytes into kidneys after IRI 
Trafficking of CD4+ and CD8+ T lymphocytes 
We have examined the trafficking of CD4+ and CD8+ T cell subsets into kidneys after 
ischemic injury (18). After 3 h of renal IRI, the percentages of CD4+  and CD4+NK1.1+ cells 
increased similarly in both sham-operated and IRI mice as compared with normal mice. 
However, 24 h after renal IRI, while the percentage of CD4+ T cells in the IRI mice was 
similar to that of control groups, the percentage of CD4+NK1.1+ cells increased (3.2%) when 
compared with normal (1.2%) and sham-operated (1.6%) mice. The percentage of CD8+  T 
cells was similar in all groups 3 and 24 h after renal IRI and no expression of NK1.1 Ag was 
observed on these cells. However, the increased percentage of the CD4+ NK1.1+  cells in the 
IRI group 24 h after renal IRI could be related to renal ischemic injury because at this time 
point serum creatinine was increasing and visible kidney structure damage was observed. 
Table 1 shows summarized results. 
Expression of CD69 on CD4+ and CD8+ T lymphocytes 
We have investigated the activation state of the intrarenal CD4+ and CD8+ T cell subsets 
analyzing the expression of activation markers CD69 and CD25 (18). After 3 h of renal IRI, 
we observed increased expression of CD69 on CD4+ T cells in sham-operated (14.7%) and 
IRI (14.2%) compared with normal mice (7.1%). CD69 expression on CD8+ T cells tended to 
increase at 3 h, but was not statistically significant. After 24 h of renal IRI, the expression of 
CD69 on CD4+ and CD8+ T cells declined to lower levels than normal mice. Moreover, no 
increased expression of CD25 Ag on CD4+ and CD8+ T cells in any of the studied groups 
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was found. Results demonstrated that CD4+ and CD8+ T lymphocytes infiltrating kidneys of 
sham-operated and IRI mice display some features of activated T lymphocytes. We 
hypothesized that T cells might be activated after renal IRI; however, we found a similarly 
increased expression of CD69 on the CD4+ and CD8+ T cells in both sham-operated and IRI 
mice 3 h after renal IRI. Results are summarized in Table 1. 
Kidney assessment and histology changes earlier after ischemia injury 
We evaluated the Ischemic kidneys following the serum creatinine levels 3 and 24 h after 
renal IRI (18). After 3 h of renal IRI, a significant increase in serum creatinine of IRI mice (n = 
8, 1.18 mg/dl) when compared with normal (n = 8, 0.50 mg/dl) and sham-operated (n = 8, 
0.70 mg/dl) mice was observed. After 24 h of renal IRI, serum creatinine significantly 
increased in the IRI mice (n = 8, 2.83 mg/dl) as compared with control groups. In the sham-
operated mice, serum creatinine was slightly increased compared with normal mice 3 h after 
surgery (Fig. 1). The kidney structural injury in the cortex and the medulla of IRI mice was 
evaluated. Compared with kidneys of normal mice (Fig. 1A) and sham-operated mice, 3 
(Fig. 1B) and 24 h (Fig. 1C) after surgery, IRI mice show slightly tubular epithelial necrosis 3 
h after renal IRI (Fig. 1D) and significant tubular injury with loss of tubular structure 24 h 
after renal IRI (Fig. 1E).  
 
 
 
 
 
Fig. 1. Kidney injury after 30-min bilateral ischemia. Serum creatinine of IRI mice () 
compared with normal (▴) and sham-operated (○) mice 3 and 24 h after renal IRI. A, Normal 
mouse kidney (no IRI). B and C, Sham-operated mice kidneys showing normal histology 3 
and 24 h after surgery, respectively. D, IRI mouse kidney showing same proteinaceous casts 
in tubules 3 h after renal IRI. E, IRI kidney showing severe damage 24 h after renal IRI. 
(Pictures used with permission and courtesy of the original authors [18]). 
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Lymphocyte 
Phenotypes 
Normal 
mice 
Early 
trafficking 
Long term 
trafficking 
 0h 3h 24h 2w 6w 11w 
CD4+ 18.6 24.8 18.5 29 51a(48)b 48 
CD8+ 8.2 10.1 9.1 16 30(21) 27 
CD4+CD69+ 7.1 14.2 5.5 17 22(29) 28 
CD8+CD69+ 2.3 4.3 0.4 9 18(15) 16 
CD4+CD44+CD62L- 57 ND ND 77 ND(96) 93 
CD8+CD44+CD62L- 49 ND ND ND 90ND ND 
CD4+NK1.1 (NKT) 1.2 1.3 3.2 1.1 2.0(0.2) 0.4 
CD4+CD25+ (FOXP3+) 1.8 ND 1.8c 2.6d ND ND 
a After 6 weeks of bilateral ischemia 
b After 6 weeks of unilateral ischemia 
c After 3 days of unilateral ischemia 
d After 10 days of unilateral ischemia
Table 1. T lymphocytes phenotypic trafficking into mouse kidney after IRI, expressed as 
cells percentages. 
4. Trafficking of T lymphocytes into kidneys long term after IRI 
Trafficking of CD4+ and CD8+ T cells 
Analysis of infiltrating lymphocytes long term after renal IRI (19, 24) revealed increased 
percentages of CD4+  (29%) and CD8+  (16%) T lymphocytes in IRI kidneys compared with 
kidneys of sham mice (CD4+ : 11% and CD8+ : 6%) after 2 weeks of bilateral renal IRI. 
However, similar percentage of CD4+  and CD8+  T cells was observed in sham and IRI 
kidneys 6 weeks after bilateral renal IRI. 6 weeks after unilateral renal IRI, we observed a 
significantly increased percentage of CD4+  (48%) and CD8+  (21%) T lymphocytes compared 
with kidneys from sham mice (CD4+ : 16% and CD8+ : 7%) and contralateral kidneys (CD4+ : 
11% and CD8+ : 5%). No changes in CD4+  and CD8+  T-cell populations were observed in 
any of the groups 11 weeks after unilateral renal IRI. Results are summarized in Table 1. The 
higher levels of CD4+  and CD8+  T cells 6 and 11 weeks after ischemia as well as the return 
to normal levels of some populations as CD69+  and CD44+  markers after 6 weeks, 
demonstrate the possible limit and suppression of the immune response after long-term 
renal IRI. Potential modulators of this immunosuppresion could be the regulatory T cells 
CD4+ CD25+  or CD4+ CD25+  FoxP3 (25, 26) as increased populations of these regulatory T 
cells have been observed in long-term allogenic transplants (27). 
Infiltrating of CD4+ and CD8+ T lymphocytes expressing CD69 
After 2 weeks of bilateral renal IRI (19), we observed an increased expression of CD69 on 
CD4+ (17%) and CD8+ (9%) T cells in IRI mice when compared with sham mice (CD4+: 6% 
and CD8+: 2%). Similarly, increased expression of CD69 on CD4+ (22%) and CD8+ (18%) T 
cells in IRI mice compared with sham mice (CD4+: 15% and CD8+: 11%) was observed after 6 
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weeks of bilateral renal IRI. Six weeks after unilateral ischemia, we observed a significantly 
increased expression of CD69 on CD4+ (29%) and CD8+ (15%) T cells compared with kidneys 
from sham mice (CD4+: 7% and CD8+: 2%) and contralateral kidneys (CD4+: 4% and CD8+: 
2%). However, 11 weeks after renal IRI, only CD4+ T cells from IRI kidneys showed 
increased expression of CD69 (28%) when compared with sham (13%) and contralateral 
(12%) kidneys. Results are summarized in Table 1. The increased infiltration of the activated 
CD69+ marker T lymphocytes in both unilateral and bilateral IRI kidneys, is consistent with 
upregulation of the early activation marker CD69 antigen observed in allograft rejections 
and some autoimmune diseases (28–31). Activated cells produce inflammatory factors 
which can participate in tissue damage including fibrosis, as observed in patients with 
systemic sclerosis and pulmonary fibrosis (32, 33). 
Infiltrating of CD4+ and CD8+ T cells displaying effector-memory phenotype 
Two weeks after bilateral renal IRI (19), significantly increased percentage of effector-memory 
CD4+CD44hiCD62L- T cells in IRI kidneys (77%) was observed when compared with kidneys 
from sham mice (54%). Six weeks after bilateral renal IRI, a significantly increased percentage 
of CD8+ CD44hiCD62L- T cells in IRI kidneys (90%) compared with sham mice (79%) was 
observed. Similarly, 6 weeks after unilateral renal IRI, the IRI kidneys showed significantly 
increased percentage of CD4+CD44hiCD62L- T cells (96%) when compared with kidneys from 
sham mice (71%) and contralateral kidneys (65%). A significant increase in percentage of 
CD4+CD44hiCD62L- T cells was observed in IRI kidneys (93%) when compared with sham 
(80%) and contralateral kidneys (75%) 11 weeks after renal IRI. Results are summarized in 
Table 1. The high levels of effector-memory CD4+CD44hiCD62L- T cells, the ‘footprints’ of an 
immune response to antigens, in both unilateral and bilateral IRI kidneys, are consistent with 
the response to self-antigens involved in the pathogenesis of skeletal and intestinal ischemia 
induced by hypoxic stress (34), indicating that immune response to renal IRI could be also 
initiated by specific antigens. 
Decreasing of NKT lymphocytes 
Similar percentage of NKT cells (CD4+NK1.1+) was observed after 2 weeks of bilateral renal 
IRI (19). However, 6 weeks after bilateral renal IRI, we found a significantly decreased 
percentage of NKT cells in IRI kidneys (2%) when compared with kidneys of sham mice 
(4%). Eleven weeks after unilateral renal IRI, decreased percentage of NKT cells was 
observed in IRI kidneys (0.4%) when compared to sham (1.91%) and contralateral kidneys 
(3.1%; Figure 4a). However, no changes were observed in mice that underwent bilateral 
renal IRI with reduced ischemia times. In Table 1 are summarized the results. The decreased 
number of NKT cells 6 and 11 weeks after bilateral and unilateral renal IRI, respectively, are 
similar to that in liver injury (35) and rheumatoid arthritis (36).  
Effect of CD+ and CD8+ T-cell depletion on kidney-cell infiltration 
To determine the pathophysiologic role of infiltrating CD4+ and CD8+ T cells long term after 
ischemia, we depleted these cells before and after unilateral ischemia during the 6-week 
experiments (19). Depletion started 24 h preischemia and 3 days postischemia and cell 
analysis by flow cytometry was performed weekly in blood and after 6 weeks in kidney 
samples. Blood was 98% depleted of CD4+ and CD8+ T cells during the 6 weeks after renal 
IRI. In kidneys, the CD4+CD69+, CD8+CD69+, CD4+CD44hiCD62L-, and CD4+NK1.1+ cells 
were also depleted by approximately 98%, in relationship with the cell profiles of 
nondepleted control mice (data are not showed).  
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Histology of structural damage after long term ischemia 
To observe the degree of structural damage of ischemic kidneys after 6 weeks of renal IRI in 
depleted mice, the kidney histology of depleted and control mice were compared. The 
damage in the cortex (Figure 2a) was similar in control and both depleted mice, however, 
medullary damage (Figure 2b) was more extensive in control and post-ischemia depleted 
mice (Figure 2c) than in preischemia depleted mice. Therefore, the reduced damage 
observed in the kidney medulla of preischemia depleted mice when compared to control 
mice could be related to the low expression of IFN-γ (Table 2). The IFN-γ produced by CD4+ 
and CD8+ T lymphocytes is involved early after renal ischemia (37, 38), and has been 
detected in acute and chronic kidney  rejections (39). However, the increased expression of 
IL-1β in postischemia depleted mice could be related to the increased structural damage of 
kidney observed and could have distant organ affects (40). 
 
 
Fig. 2. Kidney tissue from IRI mice after 2 weeks of 25 min of bilateral ischemia (a, upper 
panel) shows some proteinaceous casts in tubules compared with normal histology of 
normal and sham mouse kidneys. Kidney structure 6 weeks after unilateral renal IRI (b, 
lower panel) shows normal histology of sham and contralateral kidneys compared with 
severe kidney damage, loss of structure, and cyst formation in IRI kidneys. (Pictures used 
with permission and courtesy of the original authors [19]). 
Regulatory T (Treg) cells involved in damage inhibition and reparative phase 
Treg cells are lymphocytes with immunosuppressive properties. One important subset of 
Treg cells express CD4 and CD25 on the cell surface and the transcription factor, FoxP3 (41). 
The mechanisms of suppression by Treg cells are diverse and include: production of 
antiinflammatory cytokines such as IL-10 or TGF-ǃ, direct cell-cell contact or CTLA-4 
mediated inhibition and production of extracellular adenosine (42). Recently, Treg cells have 
been identified in normal mouse kidneys (17, 43). In WT mice, treatment with an anti-CD25 
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monoclonal antibody (PC61) selectively decreased kidney, spleen and blood CD4+  FoxP3+  
Treg cell numbers by approximately 50%, five days after PC61 treatment (44). At that time 
point, Treg cell deficiency potentiated kidney IRI, measured by plasma creatinine, acute 
tubular necrosis (ATN), neutrophil and macrophage accumulation and pro-inflammatory 
cytokine transcription in the kidney after 24 hr of reperfusion (43). In lymphocyte-deficient 
Rag-1 KO mice, adoptive transfer of WT, but not IL-10 KO, Treg cells blocked IR-induced 
inflammation and kidney injury (43). These findings demonstrate that Treg cells can directly 
suppress the early innate inflammation, induced by IR, in an IL-10 dependent manner. In a 
different study, PC61 was administered 1 day prior to IRI, and while BUN levels and ATN 
scores were no different than control antibody-treated mice at 24 hr of reperfusion, the 
necrosis failed to resolve by 72 hr in the PC61-treated mice (45). In other study, using a 
murine model of ischemic acute kidney injury it was found that the percentage of the 
CD25+ Foxp3+  Treg subset in the total kidney-infiltrating TCRβ+ CD4+  T lymphocyte 
compartment was increased from 1.8 to 2.6% in IR kidneys at 3 and 10 days (46). This 
infiltration was accompanied of an enhanced pro-inflammatory cytokine production. These 
results strongly support an important role of regulatory T cells during IRI and in kidney 
repair after IRI.  
 
Cytokines 
chemokines 
Normal 
mice 
Early 
trafficking 
Long term 
trafficking 
 
0 ha 3hb 24 hab 1wc 
6w 
(no-deple)c 
6w 
(deple)c 
IFN-ɣ (CD4) 6.0 ND 18 ND 16.0 7-8 
IFN-ɣ (CD8) 7.1 ND 19    
TNF- ǂ (CD4) 5.0 ND 19 ND 38 37-39 
TNF- ǂ (CD8) 2.2 ND 4.9    
IL-1β ND ND ND ND 18 28-45 
IL-6 ND ND ND ND 3.0 3-6 
MIP-2 ND 4.2 30.0 147.4 18 20-28 
MCP-1 ND ND 13.8 24.6 ND ND 
KC ND ND 14.9 14.0 ND ND 
IP-10 ND 3.9 8.9 14.2 ND ND 
RANTES 1.0d 2.0d ND 50d 38 35-37 
aIFN-ɣ and TNF-ǂ at 0 and 24h were determined by flow cytometry as internal cell cytokines. 
bMIP-2, MCP-1, KC, and IP-10 at 3 and 24 h were determined using qPCR 
cAll cytokines and chemokines during the long term trafficking (at 1 and 6 weeks) were determined 
using qPCR. 
dProtein levels of CCL5 (RANTES) were detected by ELISA values in pg/mg.
Table 2. Cytokines and chemokines expressed after IRI in kidney. 
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5. Upregulation of cytokines and chemokines long term after IRI 
Expression of cytokines 
Cytokine and chemokines are known to modulate lymphocyte and kidney cell interactions 
to mediate kidney injury and fibrosis. We found (19) an increased intracellular cytokine 
production of TNF-α and IFN-γ  by CD3T+ cells infiltrating kidneys after 24 hours of IRI in 
mice. This observation suggests that lymphocytes infiltrating into the postischemic kidneys 
could have a major downstream effect on later inflammation and organ dysfunction. Thus, 
not only the trafficking of T cells postischemia is a potential mechanism, but what those 
infiltrating cells are doing at the site of injury could be crucial for pathogenesis. Given that 
infiltrating T cells are activated and selectively expanded in kidney long term after IRI, we 
hypothesized that there would be a different upregulation of these molecules postischemia 
in depleted and nondepleted mice. Using real-time RT-PCR, a significant upregulation of IL-
1β, IL-6, tumor necrosis factor (TNF)-α, IFN-γ, MIP-2, and RANTES was seen 6 weeks after 
60 min of unilateral renal IRI in normal (nondepleted T cells), compared to sham and 
contralateral kidneys. Depletion of CD4 and CD8 T cells starting preischemia led to 
significant decrease in kidney IFN-γ levels. In contrast, depletion starting 3 days after 
ischemia led to significant increase in IL-1β. However, the IRI kidneys of both depleted and 
nondepleted groups had prominent expression levels of TNF-α and RANTES. As 
demonstrated in both depleted and nondepleted mice 6 weeks after unilateral ischemia, the 
cytokines and chemokines including IL-1β, IL-6, TNF-α, MIP-2, and RANTES were 
significantly upregulated. The results are summarized in the Table 2.  It has been reported 
that in moderate ischemia a modest upregulation of TNF-α and RANTES and strong 
upregulation of IL-1β, IL-6, IFN-γ, and MIP-2 exist (47), whereas after severe ischemia strong 
upregulation of TNF-α and RANTES and to a lesser extent IL-1β, IL-6, IFN-γ, and MIP-2 
occur (48, 49).  Similarly, in patients with acute rejection and chronic allograft nephropathy 
significant expression of TNF-α and RANTES were reported (49). 
Expression of CXC and CC chemokines 
Chemokines are mainly known for their ability to attract inflammatory cells to sites of 
injury. Recently, the highest levels of chemokine expression at the stage of active repair (i.e. 
7 days after ischemic injury) was observed, and temporal chemokines expression pattern in 
more detail was examinated (50). The expression of the CC and CXC chemokines at 
additional reperfusion periods after ischemic injury was evaluated to determine if there is a 
biphasic expression coinciding with the inflammatory and reparative response after 
ischemic injury. Some chemokine results are summarized in the Table 2. The four CC 
chemokines were expressed in a monophasic fashion with a clear peak 7 days after ischemic 
injury. In contrast, the CXC chemokines had a biphasic expression after ischemic injury with 
the first peak in the early (i.e. inflammatory) phase and the second peak during the 
reparative phase. The CXC chemokines Cxcl1/KC, Cxcl2/MIP-2a and Cxcl10/IP-10 had the 
highest expression during the inflammatory phase.  
6. Effect of renal ischemic injury on distant organs 
Acute kidney injury (AKI) in native kidneys is a major clinical problem with high mortality 
and morbidity in the intensive care unit. This problem remains unchanged for the past 50 
years in part because AKI is associated with extra-renal complications (51, 52, 53). Much of 
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the increased risk of death associated with AKI is usually related to multi-organ dysfunction 
including brain, heart, lungs, liver and small intestine. After kidney IRI, inflammatory 
cytokines and chemokines in plasma IL-1β, IL-6, KC (IL-8), TNF-α, TNF-β, INF-γ, IL-17A, 
C5a, and MCP-1 increased significantly which eventually could lead to develop multi-organ 
failure. (54, 55, 56). In particular, AKI caused by IRI increased pulmonary vascular 
permeability with capillary leak (57) and change of fluid absorption in alveolar epithelial 
cells (58). Inflammation and apoptosis could be important mechanisms connecting the effect 
of AKI on lung and distant organs as show in changes of inflammatory transcriptome 
identified in lung after kidney IRI (59). Studies using gene microarrays analysis found 
marked changes in immune, inflammatory, and apoptotic processes (60). Caspase-
dependent pulmonary apoptosis concurrent with activated T cell trafficking was also 
demonstrated in kidney after IRI (61). Altered gene expression associated with 
inflammation, apoptosis, and cytoskeletal structure in pulmonary endothelial cells after 
kidney IRI suggested possible mechanisms underlying the increased pulmonary 
microvascular permeability (62). Increase of IL-1β, IL-6, TNFα, MCP-1, KC (IL-8) and ICAM-
1 may act as mediators in the crosstalk between kidney and lung (55, 60, 63). AKI following  
 
IL-1, TNF-α
ICAM-1
Apoptosis
Neutrophil infiltration
I - , -
I -
t sis
tr il i filtr ti
LUNG
BRAIN
LIVER
HEART
SMALL INTESTINE
KC (IL-8), G-CSF 
GFAP & microglia
Vascular permeability
 (I - ), -  
  i r li
s l r r ilit
MCP-1
TNF-α
TNF-β
Systemic response 
IL-6
IL-1βC5a
KC (IL-8)
IL-1β, IL-6
KC(IL-8), TNF-α
MCP-1, ICAM-1
Apoptosis
Leukocyte trafficking
Vascular permeability
Dysregulated channels
I - , I -
(I - ), -
- , I -
t sis
t  tr ffi i
s l r r ilit
sr l t ls
IL-6, KC (IL-8)
IL-17A, TNF-α
MCP-1, MIP-2, ICAM-1
Oxidation products
Vacuolization
Necrosis
Apoptosis
Vascular permeability
I - ,  (I - )
I - , -
- , I - , I -
i ti  r t
li ti
r i
t i
l r r ilit
IL-6, KC (IL-8)
IL-17A, TNF-α
MCP-1, MIP-2
ICAM-1
Endothelial apoptosis
Epithelial necrosis
Vascular permeability
I - ,  (I - )
I - , -
- , I -
I -
t li l t i
it li l r i
l r r ilit
IFN-γ
IL-17A
 
Fig. 3. AKI induce distant organ effects. AKI leads to changes in distant organs, including 
brain, lungs, heart, liver, and small intestine, involving multiple inflammatory pathways, 
including increased expression of soluble pro-inflammatory mediators, innate and adaptive 
immunity, cellular apoptosis, microvascular inflammation and dysregulation of transport 
activity, oxidative stress, transcriptional responses, etc. 
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IRI has been reported to increase apoptosis and production of IL-1, TNF-α, and ICAM-1 in 
cardiac tissue (56). Changes in the microvasculature after kidney IRI were also 
demonstrated in brain and conferred susceptibility to stroke (64). In brain has been found 
increased expression of KC (IL-8), granulocyte colony-stimulating factor (G-CSF), and glial 
fibrillary acidic protein, an inflammatory marker (65). More recently, hepatic and small 
intestine dysfunction has been observed in patients suffering from AKI. Liver injury after 
ischemic shows peri-portal hepatocyte vacuolization, necrosis and apoptosis with 
inflammatory changes. Small intestinal injury after ischemic was characterized by villous 
lacteal capillary endothelial apoptosis, epithelial necrosis and increased leukocyte 
(neutrophils, macrophages and lymphocytes) infiltration. Vascular permeability was 
severely impaired in both liver and small intestine. After ischemic insult TNF-α, IL-17A and 
IL-6 levels in plasma, liver and small intestine increased significantly. Furthermore, up-
regulation of KC (IL-8), MCP-1, MIP-2, ICAM-1 has been found in liver and small intestine 
(54). The Figure 3, shows a summarized picture of the cross talking between AKI and 
several long distance organs. 
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